Neuropsychiatric Risks of COVID: New Data

The neuropsychiatric ramifications of severe COVID-19 infection appear to be no different than for other severe acute respiratory infections (SARI). Results of a large study showed risks of new neuropsychiatric illness were significantly and similarly in adults surviving either severe COVID-19 infection or other SARI, compared with the general population. This suggests that disease severity, … Read more

Do Psychotropic Meds Raise or Lower COVID Risk?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Different psychotropic medications are associated with different risks of COVID-19 in hospitalized patients with serious mental illness, a new study suggests. Investigators found that second-generation antipsychotics were associated with a 48% lower risk of COVID-19, while valproic acid was associated with … Read more

Is Leaving Your Current Job the Answer?

We have been dealing with the COVID pandemic since 2020. And due to that, there is a lot of discussion about related physician burnout. I had my own share of challenges with the pandemic, and for the most part I can relate to a majority of the people I interact with. I shared a similar … Read more

COVID-19 Accelerated Psych Problems for Critical Care Clinicians

Approximately one third of critical care workers reported some degree of depression, anxiety, or somatic symptoms in the early phase of the COVID-19 pandemic, based on survey results from 939 healthcare professionals. The emotional response of professionals in a critical care setting in the early phase of the COVID-19 pandemic has not been well-studied, write … Read more

Mental Illness Tied to COVID-19 Breakthrough Infection

Psychiatric disorders are tied to an increased risk of COVID-19 breakthrough infection, particularly among older adults, new research shows. “Psychiatric disorders remained significantly associated with incident breakthrough infections above and beyond sociodemographic and medical factors, suggesting that mental health is important to consider in conjunction with other risk factors,” the investigators, led by Aoife O’Donovan, … Read more

What Can We Do About It?

The COVID-19 pandemic and associated vaccination efforts have brought the issue of vaccine hesitancy to the forefront of media and public attention. From 2019 to 2021, the prevalence of the term “hesitancy” in titles of scientific literature has risen from 3.3% to 8.3%, and continued skepticism around the SARS-CoV-2 vaccines remains a significant barrier in … Read more

Long-Term Smell Loss in COVID-19 Tied to Brain Damage

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with COVID-19, especially those with an altered sense of smell, have significantly more axon and microvasculopathy damage in the brain’s olfactory tissue versus non-COVID patients. These new findings from a post-mortem study may explain long-term loss of smell in some … Read more

More Evidence COVID ‘Brain Fog’ Is Biologically Based

Patients with persistent cognitive impairment months after illness with mild COVID-19 have higher levels of inflammatory markers in their cerebrospinal fluid (CSF). Researchers found elevated levels of CSF immune activation and immunovascular markers in individuals with cognitive post-acute sequelae of SARS-CoV-2 infection (PASC). Patients whose cognitive symptoms developed during the acute phase of COVID-19 had … Read more

Neurocognitive Sequelae of COVID-19 After Acute Infection

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The burden of self-reported post-acute symptoms and possible sequelae, particularly fatigue and neurocognitive impairment, remains significant 6 to 12 months after acute, even among young and middle-aged adults after mild acute SARS-CoV-2 infection, … Read more

‘Staggeringly High’ Rates of Psychiatric Symptoms After COVID-19

DENVER — Neurocognitive and psychiatric symptoms of mental illness, including posttraumatic stress disorder (PTSD), are alarmingly high among patients who have previously had COVID-19 — even among those who were not hospitalized with the virus, new research shows. The findings are from an online survey of more than 800 respondents. “Regardless of how long ago … Read more